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 Hydrogen sulfide (H2S) is an important biological signaling molecule that has been 
recognized alongside nitric oxide and carbon monoxide as being a small gasotransmitter 
that is enzymatically produced and impacts multiple physiological functions. To detect 
hydrogen sulfide, there has been a focus on developing fluorescent probes to target 
particular analytes; however, fluorescent probes lack sensitivity and depth penetration due 
to background autofluorescence and light scattering. Chemiluminescence does not require 
light excitation, which greatly reduces the amount of autofluorescence and photoactivation.  
 In order to detect hydrogen sulfide in living systems with high sensitivity, a series 
of sterically stabilized 1,2-dioxetane chemiluminescent reduction-reaction based hydrogen 
sulfide probes have been synthesized. These probes are prepared in 10-11 synthetic steps, 
with key transformations including a Horner-Wadsworth-Emmons reaction to form a tetra-
substituted enol ether, a Mitsunobu reaction to install the sensing trigger, and a versatile 
Heck reaction to append electron-withdrawing groups. The final preparation of the 
sterically crowded 1,2-dioxetane proceeds in high yields and is accomplished by a [2+2] 




oxygen and the triplet state of methylene blue accessed via visible light irradiation. The 
appendage of an acetoxymethyl ester enables cell-trappability and enhances utility for 
monitoring hydrogen sulfide in living cells. These newly synthesized hydrogen sulfide 
chemiluminescent probes have been tested at a physiological relevant pH both in vitro and 
in living systems.  
 This dissertation contains the synthesis and characterization of two new hydrogen 
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Chapter 1  
Chemiluminescent Hydrogen Sulfide Probes 
1.1 Introduction 
1.1.1  Introduction to Chemiluminescence 
 
 
Figure 1. A. The Jablonski diagram depicting the photophysical process of fluorescence. 





 The Jablonski diagram depicts three energy surfaces and highlights significant 
photophysical processes. Although the diagram simplifies the energy surfaces, each energy 
surface is a combination of all a molecules vibrational modes and possible interconversions 
between chemical structures. The y-axis denotes potential energy, while Morse potentials 
are at different locations along the x-axis. 
 Photochemistry starts at the ground state (S0), and when a single molecule is 
exposed to light with an appropriate amount of energy, the molecule can be absorbed to 
the excited electronic state (S1). Then relaxation occurs, which is radiationless conversion 
of the vibrational excited states to the ground vibrational state of S1. From the ground 
vibrational state of S1, conversion back to S0 can occur with the emission of a photon 
known as fluorescence. If the excited state is accessed through a chemical reaction, then 
the emission of the photon is called chemiluminescence (Figure 1, B). If the conversion 
from S1 to S0 occurs without emitting a photon and heat is released instead, this is known 
as internal conversion. The third way to exit from S1 is through intersystem crossing. This 
consists of the interconversion of different spin states to form the triplet excited state (T1) 
without the release of a photon. Then, radiationless vibrational relaxation can occur to 
convert the excited states to the ground vibrational state of T1. The transition from the 
triplet-excited state to the ground singlet state with the emission of a photon is known as 
phosphorescence (1) (Figure 1, A).  
 Unlike fluorescence, the excited state for a chemiluminescent reaction is not 
accessed through light absorption. A chemiluminescent thermal reaction begins by 




state and the excited state are close enough in energy that essentially allows the system to 
hop over into the excited state. The reaction proceeds forward to the minimum of the 
excited state surface, and the product is produced there in the excited state. Lastly, the 
product relaxes down to the ground state with the emission of a photon (1)  
(Figure 1, B). 
 
1.1.2 Biological Roles of Hydrogen Sulfide  
 Hydrogen sulfide is commonly known as a toxic gas with a rotten egg odor and 
environmental pollutant, but in recent years hydrogen sulfide has been discovered to be an 
important biological signaling molecule and plays various roles in mammalian physiology. 
Hydrogen sulfide has joined nitric oxide (NO) and carbon monoxide (CO) as the third 
biological gasotransmitter. A gasotransmitter is a small gas molecule that is enzymatically 
produced and influences numerous physiological functions (2,3,4). For example, hydrogen 
sulfide plays a role in vasorelaxation (5), angiogenesis (6), neuromodulation (7), diabetes 
(8), and cancer (9). Understanding the biological role of H2S is much more difficult 
compared to NO and CO due to its redox activity and nucleophilic properties. (10) In order 
to understand hydrogen sulfide signaling and deepen our knowledge to the impact it has, 
hydrogen sulfide detection tools are being developed.  
 The pKa of hydrogen sulfide is 7.0 making it a weak acid. The pKa of the 
deprotonated form (HS-) is greater than 14, and under physiological conditions HS- makes 




molecule to react with electrophilic functional groups on reactive nitrogen, oxygen, and 
sulfur species.  
 
1.1.3 Enzymatic Production of Hydrogen Sulfide 
 The enzymatic production pathways of hydrogen sulfide involve three main 
enzymes: cystathionine γ-lyase (CSE), cystathionine β-synthase (CBS), and 3-
mercaptopyruvate sulfurtransferase (3-MST)/ cysteine aminotransferase (CAT) (2). Both 
CBS and CSE use vitamin B6 as a cofactor, and each pathway uses either L-cysteine or 
homocysteine to obtain the sulfur atom for hydrogen sulfide. 
 CBS can catalyze the production of hydrogen sulfide in the presence of L-cysteine. 
Additionally, CBS catalyzes the formation of cystathionine with homocysteine and the 
cofactor vitamin B6 (Figure 2). Each CBS subunit has 551 amino acids (11). The NH2 
terminal of CBS has binding cites for the cofactor pyridoxal-phosphate (PLP) and heme 
(12). The heme group plays a redox sensor role and PLP is the active form of vitamin B6 
and functions as the catalytic domain (13). The COOH terminal of CBS has a regulatory 
domain of about 140 residues (2). When this regulatory domain is deleted, CBS is activated 
(14). CBS expression is primarily found in the brain, and when the regulatory domain has 
mutations this can lead to an array of diseases (15,16). 
 Once CBS has catalyzed the production of cystathionine, CSE can generate the 
production of hydrogen sulfide and release ammonia and α-ketobutyrate (Figure 2). CSE 
is also capable of yielding hydrogen sulfide from L-cysteine, while also producing 




catalyzing L-cystine to produce thiocysteine, which can lead to the production of hydrogen 
sulfide with the use of CSE. Human deficiency of CSE can lead to metabolic disorders and 
increased risk of developing bladder cancer (17).  
 The last enzymatic hydrogen sulfide production pathway uses both CAT and MST. 
First, CAT converts L-cysteine to 3-mercaptopyruvate (Figure 2). Then MST uses 3-
mercaptopyruvate to transfer the sulfur to sulfite or an available sulfur acceptor. The direct 
product of this production pathway is sulfane sulfur not hydrogen sulfide. To obtain 
hydrogen sulfide, atomic sulfur would need to be reduced or hydrogen sulfide could be 
released from thiosulfate or persulfides (18, 19,20). MST is found in the kidney, liver, 
heart, and brain, and defects with MST have not shown any disorders (21, 22).  
 
Figure 2. Enzymatic hydrogen sulfide production pathways in mammalian cells. CBS, 
cystathionine β-synthase; CSE, cystathionine γ-lyase; CAT, cysteine aminotransferase; 




 When studying the production of hydrogen sulfide in vivo, experiments can be done 
using small-molecule inhibitors to modify the amount of hydrogen sulfide produced. For 
example, propargylglycine (PAG) is a common CSE inhibitor that is used to decrease the 
synthesis of hydrogen sulfide (23, 24). Opposite of inhibitors, enzymatic stimulators can 
be utilized to increase the release of hydrogen sulfide. A commonly used allosteric 
activator of CBS is S-adenosylmethionine (adoMet), which stimulates the production of 
more hydrogen sulfide (25, 26).  
 
 




Scheme 1. A. Methylene blue (MB) and B. monobromobimane (mBB) hydrogen sulfide 
quantification methods. 
 
 The most common hydrogen sulfide quantification methods currently used are the 
methylene blue (MB) assay and monobromobimane (mBB), which both require the sample 
to be homogeneous. These methods work for samples such as blood or serum but not for 




commonly used method that uses iron (III) chloride catalyzed electrophilic aromatic 
substitution for hydrogen sulfide detection (Scheme 1, A). The product has a characteristic 
absorbance at 670 nm that allows for quantification (27). Drawbacks from this method 
include a limit of detection of only 2 μM, which makes it difficult to differentiate between 
sulfur species (28). Additionally, highly acidic conditions are needed, which can lead to 
sulfur extraction from other biological resources and decrease the accuracy (27). Another 
commonly used hydrogen sulfide quantification method is monobromobimane (Scheme 1, 
B). This process involves the reaction between two equivalents of mBB and one equivalent 
of hydrogen sulfide. Due to mBB reacting with both hydrogen sulfide and thiols, 
fluorescence HPLC is needed for separation and quantification (28). Although this method 
has a limit of detection as low as 2 nM, it cannot be used for cellular or tissue culture 
experiments (28). Overall, methylene blue and monobromobimane are useful tools to 
detect hydrogen sulfide, but different detection methods need to be investigated to expand 





Scheme 2. Common reaction-based detection strategies for hydrogen sulfide fluorescent 
and chemiluminescent scaffolds including A. reduction, B. nucleophilic attack, and C. 




 Another hydrogen sulfide detection method is the application of  reaction-based 
luminescent probes. Similar to the methylene blue assay and the monobromobimane 
method, hydrogen sulfide detection relies on the product after hydrogen sulfide reacts with 
the probe. Although this time the product is light. This offers much greater spatiotemporal 
data and allows for live cell and tissue imaging experiments. The reaction-based 
luminescent probe detection strategy requires a hydrogen sulfide reactive site that triggers 
light emission (Scheme 2). These hydrogen sulfide triggers can be categorized into three 
main groups: reduction, nucleophilic, and metal precipitation. The most commonly used 
detection strategy is azide reduction due to the selectivity over other reactive sulfur, 
oxygen, and nitrogen species (29). Additionally, numerous hydrogen sulfide triggers have 
been made utilizing the nucleophilicity of HS-. This strategy requires hydrogen sulfide to 
attack an electrophilic functional group on the probe leading to the removal of the caging 
protecting group (29). Furthermore, metal precipitation can be used to detect hydrogen 
sulfide. For example, when a metal ion such as Cu2+ is ligated to a fluorescent molecule, 
the fluorescence is quenched. Then in the presence of hydrogen sulfide, CuS precipitates 
out and triggers the turn-on response from the fluorescent probe (30). Overall, reaction-
based luminescent detection offers greater spatiotemporal data and allows for cellular and 







Figure 3. All current chemiluminescent hydrogen sulfide probes. 
 
 In just the past two years, over one hundred hydrogen sulfide detecting fluorescent 
probes have been synthesized. This number emphasizes the importance and need of having 
a sensitive and selective spatiotemporal hydrogen sulfide detecting device. On the other 
hand, only five chemiluminescent hydrogen sulfide probes have ever been reported (31, 
32) (Figure 3). Chemiluminescence compared to fluorescence does not require light 
excitation. This notably reduces the background autofluorescence and photoactivation of 
azide functional groups. In 2013, the Pluth group published the first chemiluminescent 
hydrogen sulfide probe, which has a luminol azide structure (31). In the presence of 
hydrogen sulfide, the azide gets reduced to the amine and then subsequently reacts with 
H2O2 / HRP (horseradish peroxidase) to generate chemiluminescence. Then in 2015, the 
Lippert group published the first generation of chemiluminescent hydrogen sulfide probes 
based off of the chemically induced electron exchange luminescence (CIEEL) mechanism 
(32). Overall, chemiluminescent hydrogen sulfide probes are still in the beginning stages 
of development with much room for improvement in areas such as sensitivity, selectivity, 






1.1.5 Design of CHS-4 and CHS-5 
 
 
Scheme 3. Design strategy for hydrogen sulfide chemiluminescent probe CHS-4 and CHS-
5-AM. 
 
 This design strategy for developing highly sensitive, cell permeable 
chemiluminescent hydrogen sulfide probes consists of a scaffold with three main parts: a 
hydrogen sulfide specific protecting group, an electron withdrawing group, and a stable 
1,2- dioxetane (33) (Scheme 3). The purpose of the protecting group is to provide high 
selectivity for hydrogen sulfide against other reactive nitrogen, oxygen, or sulfur species. 
The hydrogen sulfide trigger chosen for probes CHS-4 and CHS-5-AM was the azide-
protecting group due to its selectivity and the strong reduction property of hydrogen 
sulfide. An electron-withdrawing group was added to the scaffold at the conjugated 
position to the phenolate to create a donor-acceptor pair to increase the final light emission. 
Lastly, the 1,2-dioxetane that is stabilized by the adamantane group plays an important role 








Figure 4. Chemiluminescent hydrogen sulfide probes CHS-4 and CHS-5-AM.  
 The final structure for CHS-4 and CHS-5-AM include an acrylonitrile and 
acetoxymethyl ester electron-withdrawing group, respectively (Figure 4). The 
acetoxymethyl ester makes the CHS-5-AM scaffold cell permeable, and intracellular 
esterase cleaves the acetoxymethyl ester once the probe is inside the cell in the cytoplasm. 
The addition of this particular functional group allows for cellular testing to be conducted 
without the need of a fluorescent enhancer. Furthermore, the chlorine substituent on both 
CHS-4 and CHS-5-AM reduces the pKa of the phenolate and improves the phenolate’s 
relative concentration (32). This results in the rate of chemiluminescent decomposition to 




Scheme 4. Mechanism of hydrogen sulfide detection for CHS-5-AM.  
 
 The mechanism of hydrogen sulfide detection begins with reduction of the azide-
protecting group by hydrogen sulfide and is followed by self-immolative cleavage to yield 




after decomposition through the chemically induced electron exchange luminescence 
(CIEEL) mechanism. (Scheme 4) 
 
 
Scheme 5. Mechanism for the reduction of the azide-protecting group by hydrogen 
sulfide. 
 
 The mechanism for the reduction of an azide-protecting group by hydrogen sulfide 
was recently investigated in 2015 by the Pluth group (34) (Scheme 5). The first step in the 
reduction of the azide-protecting group is the reversible attack on the terminal nitrogen of 
the azide by HS-. The terminal nitrogen is the most electrophilic, and this nucleophilic 
attack is modeled in the Staudinger reaction mechanism as well (35). This yields an anionic 
azidothiol intermediate, which is then protonated to give a neutral compound. Next, the 
attack of a second equivalent of HS- results in the formation of N2, H2S2, and a deprotonated 







Scheme 6. Chemically Induced Electron Exchange Luminescence (CIEEL) mechanism 
through A. direct chemiexcitation and B. chemiexcitation by the Back Electron Transfer 
(BET) process.  
  
 The Chemically Induced Electron Exchange Luminescence (CIEEL) mechanism 
results in light emission through electron transfer and describes the general 
chemiluminescent process. A practical CIEEL system consists of a dioxetane that is 
thermally stabilized by spiroadamantane with a protected phenolate ion. The mechanism 
begins with the removal of the protecting group by a certain analyte trigger to release the 
phenolate ion. Next, intramolecular electron transfer occurs between the phenolate ion and 




electron from the phenolate ion and transfer it to the peroxide bond (36). From here, the 
mechanism can precede either directly or through Back Electron Transfer (BET), although 
research favors the mechanism that utilizes BET (37). This mechanism occurs in a solvent 
cage between two radical molecules, which is dependent on the solvent viscosity. An 
increase in chemiexcitation is observed with an increase in solvent viscosity (38). The final 
step in the mechanism leads to light emission from the excited methyl m-oxybenzoate 
























1.2 Results and Discussion 
1.2.1 Synthesis of Chemiluminescent Hydrogen Sulfide Probes CHS-4 and CHS-5 
 




 The synthesis of CHS-5-AM began with 2-chloro-3-methoxybenzaldehyde being 
treated with trimethyl orthoformate in the presence of p-toluenesulfonic acid in methanol 
to yield the acetal compound 2. This acetal was then treated with triethyl phosphite and 
boron trifluoride diethyl etherate in DCM to give the diethyl methoxy phosphonate 
compound 3. Next, a Horner–Wadsworth–Emmons reaction was conducted by the addition 
of n-butyllithium and 2-adamantanone in THF to compound 3 to yield the enol ether 
product compound 4. Then an SN2 reaction was performed on compound 4 by treating it 
with sodium ethanethiolate and cesium carbonate in DMF. The resulting phenol product 5 
is the leaving group of the SN2 reaction. Next, the phenol was treated with N-
iodosuccidimide in toluene to yield compound 6. Then a Heck reaction was conducted with 
compound 6 by the addition of methyl acrylate, tri(o-tolyl)-phosphine, palladium (II) 
acetate, and triethyl amine in acetonitrile to form a new carbon-carbon bond yielding 
compound 7. Then compound 7 underwent a SN2 reaction attach to the hydrogen sulfide 
trigger by the addition of compound 8 and potassium carbonate in acetone to yield 
compound 9. Next, the ester group on compound 9 was subjected to hydrolysis upon the 
addition of lithium hydroxide in THF to yield compound 10. Then bromomethyl acetate 
and N,N-diisopropylethylamine were added to compound 10 in DCM to form the 
acetoxymethyl ester functional group, compound 11. Finally, CHS-5-AM was obtained 
through the formation of the 1,2-dioxetane by singlet oxygen by dissolving the scaffold in 
DCM, adding the triplet sensitizer methylene blue hydrate, bubbling oxygen through, and 






Scheme 8. Synthesis of CHS-4. 
  
 The synthesis of CHS-4 is only three steps from compound 6. First, a Heck reaction 
is conducted with compound 6, tri(o-tolyl)-phosphine, palladium (II) acetate, and triethyl 
amine in acetonitrile to yield compound 12. Then the hydrogen sulfide azide trigger, 
compound 13, is attached through a Mitsunobu reaction with the addition diethyl 
azodicarboxylate and triphenylphosphine in THF to yield compound 14. Lastly, CHS-4 is 
obtained through the use of singlet oxygen by dissolving compound 14 in DCM, adding 
the triplet sensitizer methylene blue hydrate, bubbling oxygen through, and shining light. 
(Scheme 8) 
 





 To synthesize the hydrogen sulfide azide trigger reagents, 4-aminobenzyl alcohol 
was first reacted with sodium nitrite and sodium azide in HCl to yield compound 13. Next, 
compound 8 was obtained through the addition of p-toluenesulfonyl chloride, pyridine, and 
sodium hydroxide in DCM to compound 13. (Scheme 9) 
 
1.2.2 Chemiluminescent Response of CHS-4 and CHS-5-AM 
 
 
Figure 5. Hydrogen sulfide dose dependence in vitro with Emerald II Enhancer. A. 
Timescan for 20 μM CHS-5-AM, 1 mM Na2S, and various percentages of Emerald II 
Enhancer (0, 0.2, 2, 10%) in PBS buffer (pH = 7.41). B. Timescan for 20 μM CHS-5-AM 
with 0, 50, 100, 200, 400, 800, and 1000 μM Na2S with 2 % Emerald II Enhancer in PBS 
buffer (pH = 7.41). Three replicates of each were performed on a F-7000 Hitachi 
spectrophotometer. 
 
 The chemiluminescent response for CHS-5-AM was first tested using 20 μM CHS-
5-AM, various amounts of Emerald II Enhancer (0, 0.2, 2, 10%), and 1 mM Na2S. Twenty 
minute timescans were ran at a physiologically relevant pH using PBS buffer  (pH = 7.41) 
with a F-7000 Hitachi spectrophotometer. Luminescence response appeared to increase 
with increasing amounts of the Emerald II Enhancer. Furthermore, at least 0.2% Emerald 































































this spectrophotometer (Figure 5, A). The chemiluminescent emission for CHS-5-AM was 
then tested with increasing concentrations of Na2S holding the amount of enhancer constant 
at 2%. Twenty minute time scans were conducted using 20 μM CHS-5-AM with 0, 50, 
100, 200, 400, 800, and 1000 μM Na2S with 2% Emerald II Enhancer in PBS buffer (pH = 
7.41). Instantaneous light emission was observed in a dose dependent manner under 
physiological relevant conditions (Figure 5, B). 
 
Figure 6. Detection of hydrogen sulfide in A549 cells with Emerald II Enhancer. Nine 
technical replicates across three biological replicates were performed using a Cytation 5 
Bio Tek plate reader at 37 °C. 
  
 CHS-5-AM was tested in human lung adenocarcinoma epithelial (A549) to detect 
endogenous hydrogen sulfide. CHS-5-AM was used due to its cell permeability from the 
acetoxymethyl (AM) ester functional group. The cells were first incubated with 20 μM 
CHS-5-AM for 30 minutes. Then the cells were washed with PBS to remove any 
extracellular probe. Lastly, the cells were treated with Emerald II Enhancer (2, 2, 0, 0%) 
and Na2S (1, 0, 1, 0 mM). The relative emission intensity was then recorded using a 
Cytation 5 Bio Tek plate reader at 37 °C. The cells treated with enhancer produced 
immediate light emission. The luminescence from the cells without addition of Na2S and 
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there was still observable light emission from the cells without the enhancer and treated 




Figure 7. Time scans of the chemiluminescent emission of A. 20 μM CHS-5-AM and B. 
20 μM CHS-4 and 0, 50, 100, 200, 400, 800, 1000 μM Na2S in PBS buffer (pH = 7.41). 
The integrated emission intensity of the chemiluminescent response for CHS-5-AM and 
CHS-4 is depicted in C. and D. respectively. Three replicates of each were performed using 
a Cytation 5 Bio Tek plate reader.  
 
 The response of CHS-5-AM and CHS-4 was then tested without the enhancer in 
vitro with the Cytation 5 Bio Tek plate reader due to the noticeable sensitivity difference 
compared to the F-7000 Hitachi spectrophotometer. 20 μM CHS-5-AM and CHS-4 were 
treated with 0, 50, 100, 200, 400, 800, 1000 μM Na2S in PBS buffer (pH = 7.41). Both 




































































































































in biologically relevant conditions (Figure 7, A, B). There was a 4-fold and 2-fold increase 
in integrated luminescence response from CHS-5-AM and CHS-4 respectively (Figure 7, 
C, D).  
 
1.2.3 Detection of Cellular Hydrogen Sulfide with CHS-5-AM 
 
 
Figure 8. A549 cellular response for 20 μM CHS-5-AM with 0, 500, and 1000 μM Na2S. 
Nine technical replicates across three biological replicates were performed using a Cytation 
5 Bio Tek plate reader at 37 °C. 
 
 Detection of endogenous hydrogen sulfide was then tested without enhancer with 
CHS-5-AM. The cells were first incubated with 0, 500, and 1000 μM Na2S for 1 hour. 
Then the cells were washed with PBS to remove any extracellular Na2S. Next, the cells 
were treated with 20 μM CHS-5-AM and tested immediately with the plate reader at     37 
°C. Two controls were used in this testing, one without any cells and one with cells. Both 
controls only have 20 μM CHS-5-AM and no additional Na2S. An instantaneous 
luminescence response was observed and maintained for 1 hour in a dose dependent 


































Figure 9. Integrated emission intensity of the chemiluminescent response for A549 cells 
treated with 20 μM CHS-5-AM and 0, 20, 200, 1000, and 2000 μM propargylglycine 
(PAG). Additionally, there was a control without A549 cells, only containing 20 μM CHS-
5-AM and no addition of PAG. Seven technical replicates across four biological replicates 
were performed using a Cytation 5 Bio Tek plate reader at 37 °C. 
 
 Propargylglycine (PAG) is a small molecule competitive inhibitor for the hydrogen 
sulfide producing enzyme cystathionine γ-lyase (CSE). To examine the PAG inhibition of 
endogenous hydrogen sulfide, A549 cells were incubated with 0, 20, 200, 1000, and 2000 
μM PAG for 40 minutes in complete F-12K media at 37 °C with 5% CO2. Next, the cells 
were washed with PBS, and then 20 μM CHS-5-AM was added. The Cytation 5 Bio Tek 
plate reader recorded the relative emission intensity, and the integrated emission intensity 





























































Figure 10. The MTT assay evaluating the cell viability of CHS-5-AM with 0, 0.1, 1, 10, 
and 100 μM of CHS-5-AM after an 18-hour incubation period. Three technical replicates 
across one biological replicate was performed using a Cytation 5 Bio Tek plate reader at 
37 °C by Daphne Nguyen. 
 
 The 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay 
was conducted using human lung adenocarcinoma epithelial cells (A549) that were 
purchased from ATCC. The cells were first seeded into a 96-well plate giving a total 
volume of 120 μL / well and maintained in an incubator at 37 °C with 5% CO2 for 12 hours. 
Once about 80% cell confluence was achieved, the complete F-12K media was removed, 
and the cells were washed with PBS. The cells were then treated with 0, 0.1, 1, 10, and 100 
μM of CHS-5-AM and incubated for another 18 hours in 125 μL complete  F-12K media 
per well. Next, each well was treated with 10 μL of the MTT reagent (Cayman Chemical, 
Ann Arbor, MI), mixed gently, and incubated for an additional 4 hours. Lastly, 100 μL of 
crystal dissolving solution was added to each well to dissolve the formazan crystals. Then 
the Cytation 5 Bio Tek plate reader was used to measure the absorbance at 570 nm and the 





























 To summarize, the next generation of hydrogen sulfide probes (CHS-4 and CHS-
5-AM) have been synthesized and characterized, expanding the general knowledge of 
using chemiluminescence to detect hydrogen sulfide both in vitro and in vivo. CHS-4 and 
CHS-5-AM produced instantaneous light emission in the presence of hydrogen sulfide in 
a dose dependent manner in PBS buffer at a physiologically relevant pH.  CHS-5-AM 
proves the feasibility of developing chemiluminescent, cell-permeable probes that detect 
endogenous hydrogen sulfide without the need of a fluorescent enhancer. Propargylglycine 
(PAG) inhibition of cellular hydrogen sulfide production was also examined in living A549 
cells with CHS-5-AM. Although improvement could be done on the scaffold design, CHS-
5-AM serves as a good building block to now increase sensitivity and kinetics in the next 
generations of chemiluminescent hydrogen sulfide probes.  
 
1.4 Experimental Methods 
1.4.1 General Materials and Methods 
 
All reactions were performed in dried glassware under an atmosphere of dry N2. Silica gel 
P60 (SiliCycle) was used for column chromatography, and SiliCycle 60 F254 silica gel 
(precoated sheets, 0.25 mm thick) was used for analytical thin layer chromatography. Plates 
were visualized by fluorescence quenching under UV light or by staining with iodine. 
Other reagents were purchased from Sigma-Aldrich (St. Louis, MO), Alfa Aesar (Ward 




Cayman Chemical (Ann Arbor, MI) and used without further purification. 1H NMR for 
compounds 7,13, 14, and CHS-4 were collected on a Bruker 400 MHz spectrometer in the 
Department of Chemistry at Southern Methodist University. 1H NMR for compound 2, 3, 
4, 5, 6, 8, 9, 10, 11, CHS-5-AM and 13C NMR for compounds 9, 10, 11, and CHS-5-AM 
were measured on a JEOL 500 MHz spectrometer in the Department of Chemistry at 
Southern Methodist University. All 1H and 13C NMR spectra for characterization of new 
compounds and monitoring reactions were collected in CDCl3 (Cambridge Isotope 
Laboratories, Cambridge, MA). All chemical shifts are reported in the standard notation of 
parts per million using the peak of residual proton signals of the deuterated solvent as an 
internal reference. Coupling constant units are in Hertz (Hz). Splitting patterns are 
indicated as follows: s, singlet; d, doublet; t, triplet; q, quartet; m, multiplet; dd, doublet of 
doublets; dt, doublet of triplets.  
 
 
2-chloro-1-(dimethoxymethyl)-3-methoxybenzene (2).  
2-chloro-3-methoxybenzaldehyde (5 g, 29 mmol, 1.0 equiv.) was added to dry round-
bottom flask, flushed with N2, and dissolved in 15 mL of anhydrous methanol. P-
toluenesulfonic acid (0.505 g, 2.93 mmol, 0.1 equiv.) and trimethyl orthoformate (3.2 mL, 
29 mmol, 1 equiv.) were then added to the reaction mixture. The reaction was carried out 
at room temperature and allowed to run for 24 hours under N2. After completion, the 




organic layer was then eluted with 3 x 30 mL EtOAc. Subsequently, the organic layers 
were combined and dried with Na2SO4, filtered, and concentrated under reduced pressure. 
Column chromatography (10:1 hexanes: EtOAc) yielded compound (2) (5.181 g, 23.94 
mmol, 82%) as a colorless oil. 1H NMR (500 MHz, CDCl3) δ 7.24 (s, 1H), 7.23 (s, 1H), 
6.90 (d, 1H, J = 7 Hz ), 5.64 (s, 1H), 3.88 (s, 3H), 3.37 (s, 6H). 
 
 
Diethyl ((2-chloro-3-methoxyphenyl)(methoxy)methyl)phosphonate (3). The acetal 
compound (2) (6.409 g, 29.61 mmol, 1.00 equiv.) was added to an oven-dried round-
bottom flask, flushed with N2, and dissolved in 10 mL anhydrous DCM. The reaction was 
then cooled to 0 °C in an ice bath. Boron trifluoride diethyl etherate (3.83 mL, 30.5 mmol, 
1.03 equiv.)  was then added dropwise to the flask. Then triethyl phosphite (5.23 mL, 30.5 
mmol, 1.03 equiv.) was added dropwise to the mixture, and the reaction was stirred for 10 
minutes at 0 °C.  The reaction mixture temperature was then raised to 35 °C in an oil bath 
and stirred for 2 hours while being monitored by TLC. Upon completion, the reaction was 
cooled to room temperature and quenched with 30 mL of NH4Cl. In a separatory funnel, 
the organic layer was then eluted with 3 x 30 mL of EtOAc. Then the organic layers were 
combined and dried with Na2SO4, filtered, and concentrated under reduced pressure. 
Column chromatography (10:1 hexanes: EtOAc) yielded compound (3) (7.39 g, 22.9 
mmol, 77 %) as a light brown oil. 1H NMR (500 MHz, CDCl3) δ 7.26 (s, 1H), 6.89 (s, 1H), 






Compound (3) (1.00 g, 3.09 mmol, 1.00 equiv.) was added to an oven-dried round-bottom 
flask, flushed with N2, and dissolved in 10 mL anhydrous THF. The temperature was then 
brought down to –78 °C in a dry-ice acetone bath. 2.5 M n-BuLi (1.50 mL, 3.72 mmol, 
1.20 equiv.) was then added slowly and dropwise over 10 minutes. Next, 2-adamantanone 
(0.577 g, 3.72 mmol, 1.20 equiv.) was dissolved in 5 mL anhydrous THF in a separate 
round bottom flask and then added to the reaction mixture dropwise over 10 minutes. The 
temperature is then raised to 35 °C in an oil bath and stirred for 2 hours. Subsequently, the 
temperature was raised to 90 °C and put under reflux for 1 hour. Upon completion, the 
reaction was cooled to room temperature and quenched with 30 mL of NH4Cl. The mixture 
was transferred to a separatory funnel and the organic layer was eluted with 3 x 30 mL 
EtOAc. The combined organic layers were then dried with Na2SO4, filtered, and 
concentrated under reduced pressure. Column chromatography (20: 1 hexanes: EtOAc) 
yielded compound (4) (0.683 g, 2.145 mmol, 69 %) as an amber oil. 1H NMR (500 MHz, 
CDCl3) δ 7.19 (t, 1H, J = 16 Hz), 6.89 – 6.85 (m, 2H), 3.90 (s, 3H), 3.29 (s, 3H), 3.28 (s, 







3-(((1r,3r,5R,7S)-adamantan-2-ylidene)(methoxy)methyl)-2-chlorophenol (5). The 
ether compound (4) (13.022 g, 40.897 mmol, 1.000 equiv.) was added to an oven-dried, N2 
filled flask and dissolved in 70 mL of anhydrous DMF. Sodium ethanethiolate (4.128 g, 
49.076 mmol, 1.200 equiv.) and cesium carbonate (33.31 g, 102.2 mmol, 2.50 equiv.) were 
then added to the flask. The temperature was raised to 120 °C and stirred for 24 hours under 
reflux. TLC was used to determine the completion of the reaction, and then the reaction 
was quenched with 200 mL of NH4Cl. The reaction contents were transferred to a 
separatory funnel, and the organic layer was eluted with 3 x 200 mL of EtOAc. Then the 
organic layer was washed with 3 x 250 mL of brine. Lastly, the organic layers were 
combined and dried with Na2SO4, filtered, and concentrated under reduced pressure. 
Column chromatography (5:1 hexanes:EtOAc) was used for purification to give compound 
(5) (10.557 g, 34.635 mmol, 85%) as an off-white solid. 1H NMR (500 MHz, CDCl3) δ 
7.04 (t, 1H, J = 15 Hz), 6.91 (d, 1H, J = 6 Hz), 6.72 (d, 1H, J = 6 Hz), 3.22 (s, 3H), 3.19 









Compound (5) (1.00g, 3.28 mmol, 1 equiv.) and N-iodosuccinimde (0.74 g, 3.3 mmol, 1.0 
equiv.) were added to a round-bottom flask, flushed with N2, and then dissolved in 20 mL 
of toluene. The reaction was carried out at 0 °C in an ice bath for 30 minutes. There is a 
color change from light orange to red. Upon completion, the reaction mixture was 
transferred to a separatory funnel and washed with brine. A couple of sodium thiosulfate 
pentahydrate crystals were added to the separatory funnel to quench any remaining iodine. 
Here there was a color change from red to clear after shaking the separatory funnel 
containing the sodium thiosulfate pentahydrate crystals. If the color did not become clear, 
more crystals were added. The organic layer was eluted with 3 x 30 mL of EtOAc. Then 
the organic layers were combined, dried with Na2SO4, and concentrated under reduced 
pressure. For purification, the crude product was rinsed multiple times with hexanes. A 
solid white powder crashed out giving compound (6) (0.496 g, 1.151 mmol, 35%). 1H NMR 
(500 MHz, CDCl3) δ 7.59 (d, 1H, J = 8 Hz), 6.60 (d, 1H, J = 8 Hz), 3.28 (s, 3H), 3.24 (s, 








hydroxyphenyl)acrylate (7). Compound (6) (0.123 g, 0.404 mmol, 1 equiv.), palladium 
(II) acetate (0.004 g, 0.02 mmol, 0.05 equiv.), and tri(o-tolyl)-phosphine (0.001 g, 0.004 
mmol, 0.01 equiv.) were added to an oven-dried pressure flask and flushed with N2. These 
reagents were then dissolved in 5 mL of anhydrous ACN. Then methyl acrylate (0.11 mL, 
1.2 mmol, 3 equiv.) and triethylamine (0.10 mL, 0.61 mmol, 1.5 equiv.) were added to the 
pressure flask. The reaction was then tightly capped and heated to 120 °C for 2 hours. Upon 
completion, the reaction was cooled to room temperature and quenched with 30 mL NH4Cl 
and 30 mL of brine. The reaction contents were transferred to a separatory funnel, and the 
organic layer was washed with 3 x 30 mL of EtOAc. Finally, the organic layers were 
combined, filtered, and concentrated under reduced pressure. Column chromatography 
(12:1 hexanes:EtOAc) yielded compound (7) (0.038 g, 0.098 mmol, 80%) as a brown oil. 
1H NMR (500 MHz, CDCl3) δ 7.97 (d, 1H, J = 16 Hz), 7.40 (d, 1H, J = 8 Hz), 6.88 (d, 1H, 
J = 8 Hz), 6.63 (d, 1H, J = 16 Hz), 6.35 (s, 1H), 3.84 (s, 4H), 3.33 (s, 3H), 3.29 (s, 1H), 







4-azidobenzyl 4-methylbenzenesulfonate (8) Compound (13) (1.01 g, 6.79 mmol, 1.0 
equiv.) was dissolved in 15 mL DCM in an oven-dried round bottom flask under N2 
atmosphere and cooled to 0°C. p-Toluenesulfonic anhydride (3.323 g, 10.18 mmol, 1.5 
equiv.) and pyridine (1.1 mL, 14 mmol, 2.0 equiv.) were added to the flask, stirred for 1 
hour, and monitored by TLC. Upon completion, the crude reaction was washed with sat. 
NH4Cl and brine, and eluted with 3 x 30 mL EtOAc. To purify, the crude product was 
dissolved in 10 mL diethyl ether and filtered through a cotton plug. It was then dissolved 
in 10 mL hexanes and cooled at 0°C for 1 hour. Then the supernatant was pipetted off and 
washed with 2 x 10 mL hexanes. Finally, the pure product was concentrated under reduced 
pressure yielding compound (8) (1.39 g, 4.58 mmol, 55%) and stored in the freezer. 1H 
NMR (500 MHz, CDCl3) δ 7.72 (d, 2H, J = 9 Hz), 7.26 (d, 2H, J = 9 Hz), 7.17 (d, 2H, J = 




azidobenzyl)oxy)- 3-chlorophenyl)acrylate (9) The precursor phenol compound (7) 
(0.0889g, 0.229 mmol, 1 equiv.) was added to an oven dried round bottom flask and 




mmol, 1.5 equiv.) and K2CO3 (0.134 g, 0.970 mmol, 5 equiv.) were added and the reaction 
was stirred at room temperature overnight and monitored with TLC. After completion, the 
reaction was transferred to a separatory funnel and quenched with sat. NH4Cl. The organic 
layer was eluted with 3 x 30 mL EtOAc, dried with Na2SO4, filtered, and concentrated 
under reduced pressure. Column chromatography (25:1 hexanes: EtOAc) yielded 
compound (9) (0.0204 g, 0.039 mmol, 20%) as an amber oil. 1H NMR (500 MHz, CDCl3) 
δ 7.88 (d, 1H, J = 18 Hz), 7.44 (d, 2H, J = 8 Hz), 7.41 (d, 1H, J = 10 Hz), 7.06 (d, 1H, J = 
8 Hz), 7.01 (d, 2H, J = 9 Hz), 6.42 (d, 1H, J = 16 Hz), 4.97 – 4.95 (m, 2H), 3.79 (s, 3H), 
3.30 (s, 3H), 3.25 (s, 1H), 1.94 – 1.57 (m, 15H); 13C NMR (125 MHz, CDCl3) δ 167.18, 
153.61, 140.44, 139.46, 138.89, 138.29, 132.75, 132.62, 130.59, 130.19, 129.9, 129.75, 
127.96, 125.17, 119.99, 119.31, 119.20, 77.37, 77.12, 76.86, 57.37, 51.92, 39.29, 39.13, 




azidobenzyl)oxy)- 3-chlorophenyl)acrylic acid (10) Compound (9) (0.0204 g, 0.0392 
mmol, 1 equiv.) was added to an oven dried round bottom flask and dissolved in 5 mL THF 
under a N2 atmosphere. Then 5 mL of 1 M LiOH was added and the reaction was heated 
to 80 °C under reflux for 5 hours and monitored with TLC. Upon completion, the reaction 




mL EtOAc. The organic layer was collected, dried with Na2SO4, filtered, and concentrated 
under reduced pressure. Column chromatography (8:1 hexanes:EtOAc) yielded compound 
(10) (0.0195 g, 0.385 mmol, 99%) as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.99 (d, 
1H, J = 17 Hz), 7.45 – 7.47 (m, 3H), 7.10 (d, 1H, J = 9 Hz), 7.04 (d, 2H, J = 8 Hz), 6.44 
(d, 1H, 16 Hz), 5.05 – 4.95 (m, 2H), 3.33 (s, 3H), 3.28 (s,1H), 2.01 – 1.60 (m, 15H); 13C 
NMR (125 MHz, CDCl3) δ 171.96, 153.82, 141.10, 139.39, 138.78, 132.81, 132.61, 
130.68, 129.98, 129.44, 128.02, 125.36, 119.34, 119.27, 77.38, 77.12, 76.87, 57.41, 39.29, 





((4-azidobenzyl)oxy)- 3-chlorophenyl)acrylate (11). Compound (10) (0.02g, 0.04 mmol, 
1 equiv.) was added to an oven dried round bottom flask and dissolved in 1 mL DMF under 
a N2 atmosphere. Bromomethyl acetate ( 0.02 mL, 0.2 mmol, 4 equiv.) and DIPEA (0.024 
mL, 0.14 mmol, 4 equiv.) were added, and the reaction stirred at room temperature for 4 
hours while being monitored by TLC. Upon completion, the reaction was transferred to a 
separatory funnel and quenched with sat. NH4Cl. The organic layer was eluted with 3 x 30 
mL EtOAc, dried with Na2SO4, filtered, and concentrated under reduced pressure. Column 




as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.91 (d, 1H, J = 16 Hz), 7.39 – 7.35 (m, 
3H), 7.02 (d, 1H, J = 10 Hz), 6.97 (d, 2H, J = 6 Hz), 6.36 (d, 1H, J = 14 Hz), 5.81 (s, 1H), 
5.49 (s, 1H), 4.96 – 4.85 (m, 2H),  3.26 (s, 3H), 3.21 (s, 1H), 1.95 – 1.32 (m, 15H); 13C 
NMR (125 MHz, CDCl3) δ 169.84, 165.25, 153.78, 140.75, 139.39, 138.83, 132.80, 
132.55, 130.70, 129.97, 129.38, 128.01, 125.18, 119.27, 118.70, 77.38, 77.12, 76.87, 




methoxyspiro[adamantane- 2,3'-[1,2]dioxetan]-4'-yl)phenyl)acrylate (CHS-5-AM) 
Compound (11) (10 mg, 0.017 mmol, 1 equiv.) and methylene blue hydrate (4 mg, 0.01 
mmol, 0.7 equiv.) were added to a dry flask and dissolved in 2 mL DCM. Oxygen was 
bubbled through the reaction mixture, while irradiating with a 120 W light bulb (Home 
Depot, Dallas, TX) at 0°C. After 1.5 hours, TLC indicated no starting material remained, 
the reaction mixture was concentrated under reduced pressure. The product was purified 
by column chromatography (4:1 hexanes:EtOAc) yielding compound (CHS-5-AM) (3.8 
mg, 0.0064 mmol, 37%) as an amber oil. 1H NMR (500 MHz, CDCl3) δ 7.94 (d, 1H, J = 
18 Hz), 7.55 (d, 1H, J = 12 Hz), 7.42 (d, 3H, J = 8 Hz), 7.03 (d, 3H, J = 8 Hz), 6.45 (d, 
1H, J = 17 Hz), 5.86 (s, 3H), 4.89 (s, 3H), 3.21 (s, 3H), 2.99 (s, 1H), 0.83 – 2.02 (m, 15H); 
13C NMR (125 MHz, CDCl3) δ 169.79, 166.57, 164.98, 154.18, 140.72, 140.13, 135.81, 




77.37, 77.11, 76.86, 49.83, 36.65, 33.97, 33.68, 32.72, 32.29, 31.68, 31.64, 31.59, 29.79, 





hydroxyphenyl)acrylonitrile (12). Compound (6) (0.20 g, 0.46 mmol, 1.00 equiv.) and 
palladium (II) acetate (0.011 g, 0.046 mmol, 0.10 equiv.) were added to an oven-dried 
microwavable flask, flushed with N2, and dissolved in 1 mL of acetonitrile. Then 
acrylonitrile (0.10 mL, 1.4 mmol, 3.0 equiv.) and triethylamine (0.10 mL, 0.70 mmol, 1.50 
equiv.) were added to the reaction mixture. The flask was then capped and stirred in the 
microwave for 70 minutes at 120 °C. Upon completion, the reaction was cooled to room 
temperature and quenched with 15 mL of NH4Cl and transferred to a separatory funnel. 
The organic layer was then eluted with 3 x 20 mL of EtOAc. The organic layers were then 
combined, dried with Na2SO4, filtered, and concentrated under reduced pressure. Column 
chromatography (9:1 hexanes: EtOAc) yielded compound (12)  (0.069 g, 0.19 mmol, 42 
%) as a brown oil. 1H NMR (500 MHz, CDCl3) δ 7.55 (d, 1H, J = 17 Hz), 7.25 (d, 1H, J = 
8 Hz), 6.86 (d, 1H, J = 8 Hz), 6.32 (s, 1H), 6.15 (d, 1H, J = 17 Hz), 3.29 (s, 3H), 3.24 (s, 





(4-azidophenyl)methanol (13) 4-aminobenzyl alcohol (1.0 g, 8.1 mmol, 1.0 equiv) was 
dissolved in 20 mL 10% HCl solution in a round bottom flask under N2 atmosphere and 
cooled to 0°C. Sodium nitrite (0.672 g, 9.74 mmol, 1.2 equiv.) was dissolved in 10 mL 
water, added slowly and dropwise, and allowed to stir for 30 min. Then sodium azide 
(0.8278 g, 9.74 mmol, 1.2 equiv.) was dissolved in 10 mL water, added slowly and 
dropwise, and stirred for an additional 2 hrs. The reaction was monitored by TLC. Upon 
completion, the reaction was transferred into a separatory funnel, washed with brine, eluted 
with 3 x 50 mL EtOAc. The combined organic layer was dried with Na2SO4, filtered, and 
concentrated under reduced pressure. Purification by column chromatography (5:1 
hexanes:EtOAc) yielded compound (13) (1.01 g, 6.79 mmol, 84%). 1H NMR (400 MHz, 




azidobenzyl)oxy)- 3-chlorophenyl)acrylonitrile. (14) The precursor phenol, compound 
(6) (0.035 g, 0.098 mmol, 1 equiv.) was dissolved in 3 mL anhydrous THF under a N2 
atmosphere and cooled to 0°C. Compound (13) (0.0147 g, 0.098 mmol, 1 equiv.) and 




and allowed to cool for 5 min. Then DEAD (0.02 mL, 0.1 mmol, 1.2 equiv.) was added 
and stirred for 1 hr while being monitored by TLC. Upon completion, the reaction was 
transferred to a separatory funnel and quenched with sat. NH4Cl. The organic layer was 
eluted with 3 x 25 mL EtOAc, dried with Na2SO4, filtered, and concentrated under reduced 
pressure. Column chromatography (8:1 hexanes:EtOAc) yielded compound (14) (5.2 mg, 
0.01 mmol, 11%). 1H NMR (400 MHz, CDCl3) δ 7.54 (d, 1H, J = 16 Hz), 7.43 (d, 4H, J = 
23 Hz), 7.33 (d, 2H, J = 23 Hz), 7.15 – 7.02 (m, 5H), 5.93 (d, 2H, J = 16 Hz), 5.43 (s, 1H), 




methoxyspiro[adamantane-2,3'- [1,2]dioxetan]-4'-yl)phenyl)acrylonitrile (CHS-4) 
Compound (14) (5.2 mg, 0.01 mmol, 1 equiv.) and methylene blue hydrate (4 mg, 0.01 
mmol, 0.7 equiv.) were added to a dry flask and dissolved in 2 mL DCM. Oxygen was 
bubbled through the reaction mixture, while irradiating with a 120 W light bulb (Home 
Depot, Dallas, TX) at 0°C. After 1.5 hours, TLC indicated no starting material remained, 
the reaction mixture was concentrated under reduced pressure. The product was purified 
by column chromatography (8:1 hexanes:EtOAc) yielding compound (CHS-4) (2.8 mg, 
0.0005 mmol, 51%). 1H NMR (400 MHz, CDCl3) δ 7.99 (d, 1H, J = 16 Hz), 7.54 (s, 1H), 
7.50 (s, 1H), 7.42 (d, 2H, J = 8 Hz), 7.09 (d, 2H, J = 8 Hz), 5.98 (d, 1H, J = 20 Hz), 5.01 





1.4.2 Chemiluminescent Response 
   
 The chemiluminescent response of CHS-5-AM with Emerald II Enhancer was done 
with a Hitachi-7000 Fluorescence Spectrometer (Hitachi, Tokyo, Japan, Figure 5) using 
the luminescence detection mode. 20 mM PBS buffer (pH 7.4), a 5 mM stock solution of 
CHS-5-AM (final concentration of 20 μM), and a 50 mM stock solution of Na2S made 
immediately before the experiment were used. For Figure 5, A, various percentages of 
Emerald II Enhancer were used (0, 0.2, 2, 10%) with 1 mM Na2S. For Figure 5, B, 2% 
enhancer was used with different concentrations of Na2S (0, 50, 100, 200, 400, 800, 1000 
μM). After the addition of PBS buffer, the probe, Na2S, and the enhancer, the cuvette was 
shaken gently and the time scans was performed seconds later. All experiments were 
conducted at room temperature (25–28 °C) with three replicates of each.  
 The chemiluminescent response and time scans of CHS-4 and CHS-5-AM without 
enhancer were obtained with a Cytation 5 Bio Tek plate reader (Winooski, VT, Figure 7) 
using the luminescence detection method, endpoint read type with a gain set to 135, and 
conducted at room temperature (25–28 °C). A 5mM stock solution of each probe was used 
with a 20 μM final concentration. A 50 mM stock solution of Na2S was made on the day 
of each experiment and the final concentration used varied (0, 50, 100, 200, 400, 800, 1000 
μM). Experiments were performed in 20 mM PBS buffer (pH 7.4) in a multi-well plate. 
Scans were ran immediately following the addition of PBS buffer, probe, and Na2S. Three 






1.4.3 Cellular Experiments 
 
 Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC. 
The cells were cultured in Ham’s F-12K (Kaighn’s) medium with 10% Fetal Bovine Serum 
(FBS) and 1% antibiotics (penicillin/streptomycin, 100 U/mL). Cells were kept in a 
humidified incubator at 37 °C with 5% CO2. One or two days before a cellular experiment 
was conducted, cells were plated onto a sterile multi-well plate and allowed to reach a 
confluence of 80–95% by the time of testing. All chemiluminescent responses for cellular 



















Cell Culture Protocol 
 Human lung adenocarcinoma epithelial cells (A549) were purchased from ATCC 
and is the only current cell line in the lab. Cells are kept in a humidified incubator at      37 
°C with 5% CO2.  
 The cells are cultured in Ham’s F-12K (Kaighn’s) medium supplemented with 10% 
Fetal Bovine Serum (FBS) and 1% antibiotics (penicillin/streptomycin, 100 U/mL). To 
make complete F-12K medium for culturing A549 cells follow the following steps: 
1. Turn on the UV for the hood 10 minutes prior to working in it. 
2. Spray the hood down with the 70% alcohol mixture and wipe dry with paper 
towel. 
3. Put the following items in the hood (after warming them up in the 37 °C water 
bath and then spraying with the alcohol mixture): a new bottle of incomplete F-
12K (500 mL), FBS, and the penicillin. 
4. Take out 55 mL of the incomplete F-12K media using a 55 mL pipette and 
transfer into a falcon tube. Label this falcon tube as “incomplete F-12K and the 
date”. 
5. Using another 55 mL pipette, add 50 mL of FBS to the remainder of the 




6. Then using a 5 mL pipette, add 5 mL of penicillin to the incomplete F-12K 
bottle. 
7. Swirl gently to ensure mixing without causing bubbles. 
8. Label the bottle as “Complete and date and ARL”. The mixture will be a red 
color at first and then turn to a pink color over time. 
9. Store the complete media in the fridge. 
10. The FBS is stored in Dr. Zoltowski’s lab in the –80 °C freezer. Make 4 aliquots 
of 50 mL FBS in falcon tubes to keep in the fridge before storing it the freezer. 
 
To passage A549 cells, follow the following steps: 
1. Check the confluence of the cells. The confluence should be around 80–95% 
before passaging. Otherwise, wait another day or two to allow the cells to 
proliferate more. 
2. Turn on the UV for the hood 10 minutes prior to working in it. 
3. Spray the hood down with the 70% alcohol mixture and wipe dry with paper 
towel. 
4. Put the following items in the hood (after warming them up in the 37 °C water 
bath and then spraying with the alcohol mixture): the complete F-12K media, 
trypsin, and PBS. 
5. To start, remove the cell flask from the incubator and aspirate off the old media. 
6. Wash away the dead cells by rinsing the cells with 10 mL of PBS (use a 10 mL 




7. Add 2 mL of trypsin to the flask. Move the plate around to ensure all the cells 
are coated with trypsin. Then incubate for 10 minutes to allow the trypsin to 
break the bonds between the cell surface and the flask. 
8. Then bring the flask back to the hood and add 10 mL of complete F-12K media. 
Swirl the flask slightly to make sure all the cells are in the media. 
9. Using the same 10 mL pipette, draw up the entire contents of the flask back into 
the pipette and transfer into a falcon tube. 
10. Tightly cap the flacon tube and put it into the centrifuge for 10 minutes at 1000 
rpm. 
11. Aspirate off the supernatant. Then add about 1 mL of complete media to the 
falcon tube. Disperse the cells evenly throughout by using a 1000 μL pipette 
and pipetting up and down multiple times. 
12. Add 20 mL of complete F-12K media to a new T75 flask. 
13. Add 20 μL of the cells to the flask and gently rock the flask back and forth to 
disperse the cells. Check the confluence of the cells. If more cells are needed, 
continue to add cells and check the confluence. 
14. Lastly, label the flask with the your initials, the date, the cell line (A549), and 
the passage and generation number. Store in the incubator. 
 
The frozen cells are kept in a liquid nitrogen tank and a binder is kept nearby with the 
inventory of the frozen cells. To freeze cells, follow the following steps: 
1. Freezing more cells should be done after 2 or 3 passages from newly thawed 




2. The confluence should be around 80–90 % before freezing. 
3. Prepare 10 mL the freezing media (10% cell-culture grade DMSO in complete 
media). This will make 10 vials for freezing. 
4. Follow all cell passaging steps like normal up until the centrifuge step. 
5. After the centrifuge step, aspirate off the media. 
6. Add 1 mL of the cell freezing media. Disperse the cells throughout the media 
by pipetting up and down with a 1000 μL pipette.  
7. Then add the rest of the freezing media to the falcon tube and mix. 
8. Use the cryopreservation vials to freeze the cells. Add 1 mL of the cell mixture 
to each vial.  Cap the vials tightly and label with the cell type, generation and 
passage number, date, and initials. Parafilm the lids of the vials. 
9. Put the vials in the Mr. Frosty vial container and put into the –80 °C freezer in 
Dr. Zoltowski’s lab for 3 days.  
10. After 3 days, transfer the vials into the liquid nitrogen container.  
11. Fill out the cell inventory in the liquid nitrogen storage chart. 
 
To thaw cells, follow the following steps: 
1. Turn on the UV for at least 10 minutes prior to starting. 
2. Put the complete F-12K media in the water bath and allow to reach 37 °C. 
3. Check the inventory of the cells to locate the vials in the liquid nitrogen storage 
chart. Pull up the cells from the liquid nitrogen tank- labeled as B. Let the liquid 
nitrogen drip back into the tank before pulling it all the way out. Use the thick 




4. Take out 2 vials and allow them to thaw on the counter for about 5–10 minutes.  
5. Spray down the hood with the 70% alcohol spray. 
6. In the hood, draw up the cells from the vials and transfer into a falcon tube.  
7. Add complete F-12K media to the falcon tube so the total volume is about 10 
mL. 
8. Centrifuge for 10 minutes at 1000 rpm. 
9. Then remove the media from the falcon tube, leaving the pellet of cells. 
10. Add 1 mL of complete F-12K media to the falcon tube and pipette up and down 
to mix. 
11. Add about 20 mL of complete F-12K media to a new T75 flask. 
12. Add ALL the cells from the falcon tube into the T flask. 
13. Label the flask with your initials, the date, the cell line (A549), and the passage 
and generation number. (If the cell vial thawed was labeled “P2G2”, then this 
new flask would be labeled “P1G3”. Store the cells in the incubator. 
14. The next day, remove the media and wash the cells with 10 mL PBS. Then 
aspirate off the PBS and add 20 mL of complete F-12K media. The purpose of 
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